Showing results (21-30 of 96) with videos related to
Sort By:
Pageof 10
Journal of the American Optometric Association|March 1, 1995
Circumscribed posterior keratoconusS B Eiden, R J EpsteinBiochemical and Biophysical Research Communications|April 14, 1989
Mitogen-induced topoisomerase II synthesis precedes DNA synthesis in human breast cancer cellsR J Epstein, P J SmithCancer Chemotherapy and Pharmacology|February 20, 2008
Tumor resensitization to erlotinib following brief substitution of cetuximabR J Epstein, T W LeungInvestigative Ophthalmology & Visual Science|September 1, 1987
Corneal neovascularization induced by stimulated lymphocytes in inbred miceR J Epstein, R D StultingJournal of Cataract and Refractive Surgery|June 4, 1998
Closed-chamber capsulorhexis for cataract extraction combined with penetrating keratoplastyL S Baca, R J EpsteinJournal of Cellular Biochemistry|June 25, 1999
Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanismG Huang, A Chantry, R J EpsteinCellular Signalling|June 18, 1999
Intensification of growth factor receptor signalling by phorbol treatment of ligand-primed cells implies a dimer-stabilizing effect of protein kinase C-dependent juxtamembrane domain phosphorylationT Gulliford, X Ouyang, R J EpsteinCarcinogenesis|December 17, 1998
The duration of phorbol-inducible ErbB2 tyrosine dephosphorylation parallels that of receptor endocytosis rather than threonine-686 phosphorylation: implications for the physiological role of protein kinase C in growth factor receptor signallingX Ouyang, T Gulliford, R J EpsteinAmerican Journal of Surgery|May 1, 1984
Subclavian artery occlusion 42 years after mastectomy and radiotherapyW F Hughes, C L Carson, H A LaffayeThe Biochemical Journal|May 16, 1998
Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interactionG C Huang, X Ouyang, R J EpsteinPageof 10